Corcept Therapeutics Inc CORT
996 filings, 7 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 77 events
- Nov 14, 2026 SEC letter SEC asked 2 questionsletters Sep 12, 2017 to Sep 25, 2017 · Revenue, Results discussion (MD&A)
- Nov 10, 2026 Planned sale DANIEL SWISHER JR. (Director) gave notice of a planned sale of 1,500 shares worth about $113KForm 144, approximate sale date Nov 10, 2026, under a 10b5-1 plan adopted Aug 3, 2026
- Nov 3, 2026 Planned sale Daniel N. Swisher, Jr. (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 180,000 shares, runs to Oct 31, 2027
- Nov 3, 2026 Planned sale Atabak Mokari (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 200,000 shares, runs to Nov 14, 2027
- Nov 3, 2026 Planned sale William Guyer (Chief Development Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 360,000 shares, runs to May 31, 2028
- Nov 3, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 3, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 1, 2026 Planned sale Lyon Joseph Douglas (Officer) gave notice of a planned sale of 10,000 shares worth about $1.2MForm 144, approximate sale date Oct 1, 2026, under a 10b5-1 plan adopted Jun 10, 2026
- Sep 23, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Sep 15, 2026 Planned sale WILSON JAMES N (Director) gave notice of a planned sale of 30,000 shares worth about $3.3MForm 144, approximate sale date Sep 15, 2026, under a 10b5-1 plan adopted Mar 17, 2026
- Sep 14, 2026 Planned sale Lyon Joseph Douglas (Officer) gave notice of a planned sale of 10,000 shares worth about $1.1MForm 144, approximate sale date Sep 14, 2026, under a 10b5-1 plan adopted Jun 10, 2026
- Sep 2, 2026 Planned sale Vieira Roberto Wandenkolk (Officer) gave notice of a planned sale of 75,295 shares worth about $8.3MForm 144, approximate sale date Sep 2, 2026, under a 10b5-1 plan adopted Jun 17, 2026
- Aug 26, 2026 Planned sale KIMBERLY PARK (Director) gave notice of a planned sale of 26,685 shares worth about $3.3MForm 144, approximate sale date Aug 26, 2026
- Aug 25, 2026 Planned sale Maduck Sean (Officer) gave notice of a planned sale of 175,000 shares worth about $22.0MForm 144, approximate sale date Aug 25, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- Aug 18, 2026 Planned sale MAHONEY DAVID L (Director) gave notice of a planned sale of 103,606 shares worth about $12.2MForm 144, approximate sale date Aug 18, 2026, under a 10b5-1 plan adopted May 19, 2026
- Aug 17, 2026 Planned sale Robb Gary Charles (Officer) gave notice of a planned sale of 10,000 shares worth about $1.2MForm 144, approximate sale date Aug 17, 2026
- Aug 4, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $2.3MForm 144, approximate sale date Aug 4, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Aug 3, 2026 Planned sale Lyon Joseph Douglas (Officer) gave notice of a planned sale of 1,540 shares worth about $176KForm 144, approximate sale date Aug 3, 2026
- Jul 30, 2026 Planned sale Mokari Atabak (Officer) gave notice of a planned sale of 40,000 shares worth about $4.6MForm 144, approximate sale date Jul 30, 2026, under a 10b5-1 plan adopted Dec 12, 2025
- Jul 29, 2026 Planned sale David L. Mahoney (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 103,606 shares, runs to Nov 11, 2027
- Jul 29, 2026 Planned sale Joseph D. Lyon (Chief Accounting & Technology Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 120,000 shares, runs to Aug 31, 2027
- Jul 29, 2026 Planned sale Joseph K. Belanoff, M.D. (Chief Executive Officer and Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 400,000 shares, runs to Aug 31, 2027
- Jul 29, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 29, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 7, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $1.9MForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Jun 17, 2026 8-K Other events8-K item 8.01
- Jun 16, 2026 Planned sale WILSON JAMES N (Director) gave notice of a planned sale of 30,000 shares worth about $2.5MForm 144, approximate sale date Jun 16, 2026, under a 10b5-1 plan adopted Mar 17, 2026
- Jun 16, 2026 Planned sale MAHONEY DAVID L (Director) gave notice of a planned sale of 20,000 shares worth about $1.7MForm 144, approximate sale date Jun 16, 2026
- Jun 3, 2026 8-K Other events8-K item 8.01
- Jun 2, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $1.4MForm 144, approximate sale date Jun 2, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Jun 1, 2026 Planned sale BELANOFF JOSEPH K (Officer) gave notice of a planned sale of 12,837 shares worth about $892KForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Nov 26, 2024
- Jun 1, 2026 Planned sale Mokari Atabak (Officer) gave notice of a planned sale of 160,000 shares worth about $11.2MForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Dec 12, 2025
- May 28, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 27, 2026 Planned sale Maduck Sean (Officer) gave notice of a planned sale of 150,000 shares worth about $9.8MForm 144, approximate sale date May 27, 2026, under a 10b5-1 plan adopted Dec 8, 2025
- May 20, 2026 Planned sale Lyon Joseph Douglas (Officer) gave notice of a planned sale of 5,000 shares worth about $291KForm 144, approximate sale date May 20, 2026
- May 5, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $1.0MForm 144, approximate sale date May 5, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- May 1, 2026 Planned sale BELANOFF JOSEPH K (Officer) gave notice of a planned sale of 40,000 shares worth about $1.9MForm 144, approximate sale date May 1, 2026, under a 10b5-1 plan adopted Nov 26, 2024
- Apr 30, 2026 Planned sale James N. Wilson (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 100,000 shares, runs to Mar 15, 2027
- Apr 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 7, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $817KForm 144, approximate sale date Apr 7, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Mar 25, 2026 Planned sale BELANOFF JOSEPH K (Officer) gave notice of a planned sale of 40,000 shares worth about $1.4MForm 144, approximate sale date Mar 25, 2026, under a 10b5-1 plan adopted Nov 26, 2024
- Mar 25, 2026 8-K Other events8-K item 8.01
- Mar 4, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $706KForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Feb 24, 2026 Planned sale Sean Maduck (President, Corcept Endocrinology) adopted a 10b5-1 trading planreported in the 10-K, up to 600,000 shares, runs to Jun 30, 2027
- Feb 24, 2026 Planned sale Atabak Mokari (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 200,000 shares, runs to Mar 14, 2027
- Feb 24, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 24, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 19, 2026 8-K Other events8-K item 8.01
- Feb 3, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $814KForm 144, approximate sale date Feb 3, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Jan 22, 2026 8-K Other events8-K item 8.01
- Jan 6, 2026 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $699KForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted Nov 27, 2024
- Dec 31, 2025 8-K Other events8-K item 8.01
- Dec 11, 2025 SEC letter SEC asked 1 question about Form 10-K for the Fiscal Year Ended December 31, 2024letters Sep 18, 2025 to Dec 11, 2025 · Segments
- Dec 2, 2025 Planned sale Guyer William (Officer) gave notice of a planned sale of 20,000 shares worth about $1.6MForm 144, approximate sale date Dec 2, 2025, under a 10b5-1 plan adopted Nov 27, 2024
- Dec 1, 2025 Planned sale Lyon Joseph Douglas (Officer) gave notice of a planned sale of 5,000 shares worth about $397KForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 30, 2024
- Dec 1, 2025 Planned sale Maduck Sean (Officer) gave notice of a planned sale of 20,000 shares worth about $1.6MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Sep 5, 2024
- Dec 1, 2025 Planned sale BELANOFF JOSEPH K (Officer) gave notice of a planned sale of 40,000 shares worth about $3.2MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Nov 26, 2024
- Nov 25, 2025 Planned sale Guyer William (Officer) gave notice of a planned sale of 4,500 shares worth about $364KForm 144, approximate sale date Nov 25, 2025
- Nov 4, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 14, 2025 8-K Material agreement ended8-K item 1.02
- Oct 6, 2025 8-K Director or officer change8-K item 5.02
- Sep 10, 2025 8-K Other events8-K item 8.01
- Jul 31, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 31, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 14, 2025 8-K Other events8-K item 8.01
- Jun 16, 2025 8-K Shareholder vote results8-K item 5.07
- May 5, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 5, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 31, 2025 8-K Other events8-K item 8.01
- Mar 3, 2025 8-K Other events8-K item 8.01
- Feb 26, 2025 Planned sale Joseph K. Belanoff, M.D. (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 400,000 shares, runs to Aug 31, 2026
- Feb 26, 2025 Planned sale William Guyer (Chief Development Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 360,000 shares, runs to Aug 31, 2026
- Feb 26, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 26, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Dec 30, 2024 8-K Other events8-K item 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 4 | Insider trade |
| Nov 10, 2026 | 144 | Notice of planned insider sale |
| Nov 4, 2026 | 4 | Insider trade |
| Nov 4, 2026 | 4 | Insider trade |
| Nov 3, 2026 | 10-Q | Quarterly report |
| Nov 3, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 3 | New insider |
| Oct 1, 2026 | 144 | Notice of planned insider sale |
| Sep 28, 2026 | 4 | Insider trade |
| Sep 23, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 16, 2026 | 4 | Insider trade |
| Sep 16, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 14, 2026 | 144 | Notice of planned insider sale |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 4 | Insider trade |
| Sep 3, 2026 | 3 | New insider |
| Sep 2, 2026 | 144 | Notice of planned insider sale |
| Aug 28, 2026 | 4 | Insider trade |
| Aug 27, 2026 | 4 | Insider trade |
| Aug 26, 2026 | 144 | Notice of planned insider sale |
| Aug 25, 2026 | 144 | Notice of planned insider sale |
| Aug 20, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 144 | Notice of planned insider sale |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 17, 2026 | 144 | Notice of planned insider sale |
| Aug 14, 2026 | 4 | Insider trade |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 12, 2026 | 4 | Insider trade |
| Aug 12, 2026 | 4 | Insider trade |
| Aug 6, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 4 | Insider trade |
| Aug 5, 2026 | 4 | Insider trade |
| Aug 4, 2026 | 144 | Notice of planned insider sale |
| Aug 3, 2026 | 144 | Notice of planned insider sale |
| Aug 3, 2026 | 4 | Insider trade |
| Jul 30, 2026 | 144 | Notice of planned insider sale |
| Jul 29, 2026 | 10-Q | Quarterly report |
| Jul 29, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 8, 2026 | 4 | Insider trade |
| Jul 8, 2026 | 4 | Insider trade |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jul 6, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 8-K | Other events |
| Jun 17, 2026 | 4 | Insider trade |
| Jun 16, 2026 | 144 | Notice of planned insider sale |
| Jun 16, 2026 | 144 | Notice of planned insider sale |
| Jun 4, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 4 | Insider trade |
| Jun 3, 2026 | 8-K | Other events |
| Jun 2, 2026 | 144 | Notice of planned insider sale |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | 4 | Insider trade |
| May 29, 2026 | S-8 | Shares registered for employee plans |
| May 28, 2026 | 8-K | Director or officer change, Shareholder vote results |
| May 27, 2026 | 144 | Notice of planned insider sale |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 26, 2026 | 4 | Insider trade |
| May 20, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | 4 | Insider trade |
| May 7, 2026 | 4 | Insider trade |
| May 5, 2026 | 144 | Notice of planned insider sale |
| May 5, 2026 | 4 | Insider trade |
| May 1, 2026 | 144 | Notice of planned insider sale |
| Apr 30, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Apr 24, 2026 | 4 | Insider trade |
| Apr 21, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Apr 17, 2026 | DEF 14A | Proxy statement |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CORT/export.csv") into a cell.